In conclusion, obesity-associated defective estrogen signaling allows easier survival for ER-negative tumors than for ER-positive ones, resulting in a relative accumulation of ER-negative and TNBC-type tumors among patients with central obesity [87]. This evidence concerns the gene ESR1 and Obesity.